Angiography predicts aneurysm occlusion in patients treated with flow diversion, suggesting new biomarker potential.
Diluted 3DRA was identified as the optimal modality. BBS aligned with the concurrent aneurysm occlusion status and predicted subsequent complete occlusion, supporting its potential as a neointimal biomarker after FD treatment. WCS may reflect immature neointimal formation after FD.
No takes yet. Share an insight, caveat, or question.
Egashira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: